Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (131-140 of 253) with videos related to

Pageof 26
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 14, 2011
A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastomaNicolas U Gerber, Katja von Hoff, André O von Bueren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysisStefan Rutkowski, Katja von Hoff, Angela Emser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratificationAndrey Korshunov, Marc Remke, Wiebke Werft, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2009
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91Katja von Hoff, Bernward Hinkes, Nicolas U Gerber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiformeSteven De Vleeschouwer, Steffen Fieuws, Stefan Rutkowski, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studiesKlaus Müller, Martin Mynarek, Isabella Zwiener, et al.
Acta Neuropathologica|April 12, 2021
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtypeCatena Kresbach, Mario M Dorostkar, Abigail K Suwala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociStefan Pfister, Marc Remke, Axel Benner, et al.
Clinical Chemistry|August 25, 2023
Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal FluidAnn-Kristin Afflerbach, Christian Rohrandt, Björn Brändl, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Pageof 26

Showing results (131-140 of 253) with videos related to

Sort By:
Pageof 26
European Journal of Cancer (Oxford, England : 1990)|December 14, 2011
A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastomaNicolas U Gerber, Katja von Hoff, André O von Bueren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysisStefan Rutkowski, Katja von Hoff, Angela Emser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratificationAndrey Korshunov, Marc Remke, Wiebke Werft, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2009
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91Katja von Hoff, Bernward Hinkes, Nicolas U Gerber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiformeSteven De Vleeschouwer, Steffen Fieuws, Stefan Rutkowski, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studiesKlaus Müller, Martin Mynarek, Isabella Zwiener, et al.
Acta Neuropathologica|April 12, 2021
Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtypeCatena Kresbach, Mario M Dorostkar, Abigail K Suwala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociStefan Pfister, Marc Remke, Axel Benner, et al.
Clinical Chemistry|August 25, 2023
Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal FluidAnn-Kristin Afflerbach, Christian Rohrandt, Björn Brändl, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Pageof 26